163 related articles for article (PubMed ID: 33024270)
1. Thymidylate synthase drives the phenotypes of epithelial-to-mesenchymal transition in non-small cell lung cancer.
Siddiqui MA; Gollavilli PN; Ramesh V; Parma B; Schwab A; Vazakidou ME; Natesan R; Saatci O; Rapa I; Bironzo P; Schuhwerk H; Asangani IA; Sahin O; Volante M; Ceppi P
Br J Cancer; 2021 Jan; 124(1):281-289. PubMed ID: 33024270
[TBL] [Abstract][Full Text] [Related]
2. Thymidylate synthase is functionally associated with ZEB1 and contributes to the epithelial-to-mesenchymal transition of cancer cells.
Siddiqui A; Vazakidou ME; Schwab A; Napoli F; Fernandez-Molina C; Rapa I; Stemmler MP; Volante M; Brabletz T; Ceppi P
J Pathol; 2017 Jun; 242(2):221-233. PubMed ID: 28337746
[TBL] [Abstract][Full Text] [Related]
3. New prognostic indicator for non-small-cell lung cancer, quantitation of thymidylate synthase by real-time reverse transcription polymerase chain reaction.
Shintani Y; Ohta M; Hirabayashi H; Tanaka H; Iuchi K; Nakagawa K; Maeda H; Kido T; Miyoshi S; Matsuda H
Int J Cancer; 2003 May; 104(6):790-5. PubMed ID: 12640689
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and predictive significance of thymidylate synthase protein expression in non-small cell lung cancer: a systematic review and meta-analysis.
Liu Q; Yu Z; Xiang Y; Wu N; Wu L; Xu B; Wang L; Yang P; Li Y; Bai L
Cancer Biomark; 2015; 15(1):65-78. PubMed ID: 25524944
[TBL] [Abstract][Full Text] [Related]
5. Salinomycin acts through reducing AKT-dependent thymidylate synthase expression to enhance erlotinib-induced cytotoxicity in human lung cancer cells.
Tung CL; Chen JC; Wu CH; Peng YS; Chen WC; Zheng HY; Jian YJ; Wei CL; Cheng YT; Lin YW
Exp Cell Res; 2017 Aug; 357(1):59-66. PubMed ID: 28454878
[TBL] [Abstract][Full Text] [Related]
6. Expression of thymidylate synthase in human non-small cell lung cancer.
Otake Y; Tanaka F; Yanagihara K; Hitomi S; Okabe H; Fukushima M; Wada H
Jpn J Cancer Res; 1999 Nov; 90(11):1248-53. PubMed ID: 10622537
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of the polymorphisms in thymidylate synthase and methylenetetrahydrofolate reductase gene in lung cancer.
Takehara A; Kawakami K; Ohta N; Oyama K; Ota Y; Oda M; Watanabe G
Anticancer Res; 2005; 25(6C):4455-61. PubMed ID: 16334126
[TBL] [Abstract][Full Text] [Related]
8. Thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer: relationship between mRNA expression and activity.
Miyoshi T; Kondo K; Fujino H; Takahashi Y; Sawada N; Sakiyama S; Tsuyuguchi M; Kimura S; Sumitomo M; Monden Y
Anticancer Res; 2005; 25(2A):923-30. PubMed ID: 15868929
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4
Liu L; Zhu H; Liao Y; Wu W; Liu L; Liu L; Wu Y; Sun F; Lin HW
Biomed Pharmacother; 2020 Jul; 127():110225. PubMed ID: 32428834
[TBL] [Abstract][Full Text] [Related]
10. High-grade neuroendocrine carcinoma of the lung shows increased thymidylate synthase expression compared to other histotypes.
Ibe T; Shimizu K; Nakano T; Kakegawa S; Kamiyoshihara M; Nakajima T; Kaira K; Takeyoshi I
J Surg Oncol; 2010 Jul; 102(1):11-7. PubMed ID: 20578072
[TBL] [Abstract][Full Text] [Related]
11. CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer.
Tu Z; Xie S; Xiong M; Liu Y; Yang X; Tembo KM; Huang J; Hu W; Huang X; Pan S; Liu P; Altaf E; Kang G; Xiong J; Zhang Q
Int J Oncol; 2017 Feb; 50(2):505-514. PubMed ID: 28000861
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal circulating tumor cells (CTCs) and OCT4 mRNA expression in CTCs for prognosis prediction in patients with non-small-cell lung cancer.
Li S; Chen Q; Li H; Wu Y; Feng J; Yan Y
Clin Transl Oncol; 2017 Sep; 19(9):1147-1153. PubMed ID: 28374320
[TBL] [Abstract][Full Text] [Related]
13. Tripartite motif 16 inhibits epithelial-mesenchymal transition and metastasis by down-regulating sonic hedgehog pathway in non-small cell lung cancer cells.
Huo X; Li S; Shi T; Suo A; Ruan Z; Yao Y
Biochem Biophys Res Commun; 2015 May; 460(4):1021-8. PubMed ID: 25843803
[TBL] [Abstract][Full Text] [Related]
14. The circRNA circPTPRA suppresses epithelial-mesenchymal transitioning and metastasis of NSCLC cells by sponging miR-96-5p.
Wei S; Zheng Y; Jiang Y; Li X; Geng J; Shen Y; Li Q; Wang X; Zhao C; Chen Y; Qian Z; Zhou J; Li W
EBioMedicine; 2019 Jun; 44():182-193. PubMed ID: 31160270
[TBL] [Abstract][Full Text] [Related]
15. KIAA1199 promotes invasion and migration in non-small-cell lung cancer (NSCLC) via PI3K-Akt mediated EMT.
Tang Z; Ding Y; Shen Q; Zhang C; Li J; Nazar M; Wang Y; Zhou X; Huang J
J Mol Med (Berl); 2019 Jan; 97(1):127-140. PubMed ID: 30478628
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone pretreatment impairs the thymidylate synthase inhibition mediated flare in thymidine salvage pathway activity in non-small cell lung cancer.
Chen X; Yang Y; Katz SI
PLoS One; 2018; 13(8):e0202384. PubMed ID: 30142195
[TBL] [Abstract][Full Text] [Related]
18. Exosomes derived from mesenchymal non-small cell lung cancer cells promote chemoresistance.
Lobb RJ; van Amerongen R; Wiegmans A; Ham S; Larsen JE; Möller A
Int J Cancer; 2017 Aug; 141(3):614-620. PubMed ID: 28445609
[TBL] [Abstract][Full Text] [Related]
19. The deubiquitinating enzyme UCHL1 promotes resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase.
Ding X; Gu Y; Jin M; Guo X; Xue S; Tan C; Huang J; Yang W; Xue M; Zhou Q; Wang W; Zhang Y
Theranostics; 2020; 10(13):6048-6060. PubMed ID: 32483437
[No Abstract] [Full Text] [Related]
20. Significance of thymidylate synthase and thyroid transcription factor 1 expression in patients with nonsquamous non-small cell lung cancer treated with pemetrexed-based chemotherapy.
Sun JM; Han J; Ahn JS; Park K; Ahn MJ
J Thorac Oncol; 2011 Aug; 6(8):1392-9. PubMed ID: 21716147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
